Evidence map›Paper›PMID 39810169›Full record

ArticleEuropean journal of medical research2025

Integrating the A

Sarawut Krongsut, Nat Na-Ek, Atiwat Soontornpun, Niyada Anusasnee

Abstract readValidation Study
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarawut KrongsutDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Saraburi Hospital, Saraburi, Thailand. sarawut-kron@moph.go.th.
Nat Na-EkDivision of Pharmacy Practice, Department of Pharmaceutical Care, School of Pharmaceutical Sciences, University of Phayao, Phayao, Thailand.
Atiwat SoontornpunDivision of Neurology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Niyada AnusasneeDivision of Radiology, Saraburi Hospital, Saraburi, Thailand.

Funding

Medical Education Center at Saraburi Hospital MC001-2567
6 · The paper itself

Abstract

introductionStroke-associated pneumonia (SAP) is a major cause of mortality during the acute phase of stroke. The A

methodsThis retrospective cohort study included thrombolyzed AIS patients at Saraburi Hospital, Thailand. The combined A

resultsOf 345 AIS patients, 20.3% developed SAP. The combined A

conclusionsThe combined A

Indexed as

Erythrocyte IndicesPneumoniaStrokeThrombolytic TherapyAgedComputed Tomography AngiographyFemaleFibrinolytic AgentsHumansInfusions, IntravenousMaleMiddle AgedPrognosisRetrospective StudiesRisk AdjustmentROC CurveFibrinolytic AgentsA2DS2 scoreASPECTSIschemic strokeStroke-associated pneumoniaThrombolysis

Identifiers

PMID39810169
PMCPMC11734527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.